ConductScience.org, home

Paper42395877

Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review.

Su S and 4 others. Front Cardiovasc Med, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review. Papers, record 42395877. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42395877

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Engineered extracellular vesicles for ischemic heart diseases: modification methods, targeted delivery strategies, and multi-modal therapies - A systematic review.
PubMed
Journal
Front Cardiovasc Med
PubMed
Year
2026
PubMed
Publication types
Journal Article, Systematic Review
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Su SSha
2Teng YYu
3Liu SShaojiao
4Wang LLei
5Zhao MMingjing

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References106

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140453695Human induced pluripotent stem cell derived nanovesicles for cardiomyocyte protection and proliferation.Bioact Mater2025https://conductscience.org/library/papers/40453695PubMed
232076644Targeted anti-IL-1β platelet microparticles for cardiac detoxing and repair.Sci Adv2020https://conductscience.org/library/papers/32076644PubMed
340514650Nanoscale engineered exosomes for dual delivery of Sirtuin3 and insulin to ignite mitochondrial recovery in myocardial ischemia-reperfusion.J Nanobiotechnology2025https://conductscience.org/library/papers/40514650PubMed
438001231Coronary microvascular obstruction and dysfunction in patients with acute myocardial infarction.Nat Rev Cardiol2024https://conductscience.org/library/papers/38001231PubMed
529556361Targeting regenerative exosomes to myocardial infarction using cardiac homing peptide.Theranostics2018https://conductscience.org/library/papers/29556361PubMed
640064701Platelet Membrane and miR-181a-5p Doubly Optimized Nanovesicles Enhance Cardiac Repair Post-Myocardial Infarction through Macrophage Polarization.ACS Appl Mater Interfaces2025https://conductscience.org/library/papers/40064701PubMed
717003929Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix.Thromb Haemost2006https://conductscience.org/library/papers/17003929PubMed
841152363Targeting SYK with miR-512-3p provides therapeutic potential in myocardial fibrosis.Sci Rep2025https://conductscience.org/library/papers/41152363PubMed
937439246Exosomes: current knowledge and future perspectives.Tissue Barriers2024https://conductscience.org/library/papers/37439246PubMed
1023584393Extracellular vesicles: biology and emerging therapeutic opportunities.Nat Rev Drug Discov2013https://conductscience.org/library/papers/23584393PubMed
1140886088Participation of Women in Cardiovascular Trials From 2017 to 2023: A Systematic Review.JAMA Netw Open2025https://conductscience.org/library/papers/40886088PubMed
1232145393Pre-culture of mesenchymal stem cells within RGD-modified hyaluronic acid hydrogel improves their resilience to ischaemic conditions.Acta Biomater2020https://conductscience.org/library/papers/32145393PubMed
1321501867Cell penetrating peptide conjugated bioreducible polymer for siRNA delivery.Biomaterials2011https://conductscience.org/library/papers/21501867PubMed
1441919239Mechanisms and emerging research trends of angiogenesis promotion by small extracellular vesicles from different cellular sources in alleviating myocardial infarction injury.Front Pharmacol2026https://conductscience.org/library/papers/41919239PubMed
1538417558Locally delivered hydrogels with controlled release of nanoscale exosomes promote cardiac repair after myocardial infarction.J Control Release2024https://conductscience.org/library/papers/38417558PubMed
1633621039A Novel Peptide-Equipped Exosomes Platform for Delivery of Antisense Oligonucleotides.ACS Appl Mater Interfaces2021https://conductscience.org/library/papers/33621039PubMed
1732278100MiR-101a loaded extracellular nanovesicles as bioactive carriers for cardiac repair.Nanomedicine2020https://conductscience.org/library/papers/32278100PubMed
1836325775[MicroRNA-204 Carried by Exosomes of Human Umbilical Cord-derived Mesenchymal Stem Cells Regulates the Polarization of Macrophages in a Mouse Model of Myocardial Ischemia-reperfusion Injury].Zhongguo Yi Xue Ke Xue Yuan Xue Bao2022https://conductscience.org/library/papers/36325775PubMed
1941674372Fusogenic Hybrid Gelled Nanovesicles Combining Mesenchymal Stromal Cell Cargo with Cholesterol-Modified Macrophage Membranes for Targeted Myocardial Infarction Therapy.ACS Nano2026https://conductscience.org/library/papers/41674372PubMed
2033664870Engineering extracellular vesicles with platelet membranes fusion enhanced targeted therapeutic angiogenesis in a mouse model of myocardial ischemia reperfusion.Theranostics2021https://conductscience.org/library/papers/33664870PubMed

See all 106 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42395877

GET https://conductscience.org/api/papers/v1/42395877/references?page=2